pharmaceutical and medical preparations for the prediction of drug treatment efficacy; pharmaceutical and medical preparations for prognosis related t Read More

Classification Information

Class [005]
Pharmaceutical and medical preparations for the prediction of drug treatment efficacy; pharmaceutical and medical preparations for prognosis related to cancer; diagnostic kits consisting primarily of monoclonal antibodies for use in disease testing, specifically in oncology and premalignant disorders and benign tumors; reagents for medical use, namely, for medical diagnosis, drug-tailored efficacy predication and analysis; clinical medical reagents; diagnostic preparations for medical and veterinary purposes; diagnostic test materials for medical use in the field of oncology in the form of a clinical biomarker signature assay on biopsy or other patient sample material for measuring biomarkers reflective of disease-driving processes that the drug inhibits or does not inhibit to predict treatment efficacy within oncology; diagnostic preparations for medical use; diagnostic biomarker reagents for medical purposes; companion diagnostic biomarker reagents for medical purposes.

Classification kind code

Class [044]
Medical services; medical testing for diagnosis or treatment purposes; medical diagnostic testing, monitoring, and reporting services; providing medical information, consultancy and advisory services; individual medical counseling services provided to patients; providing information in the fields of oncology and precision medicine via a website; providing medical information to medical professionals in the form of reports in the fields of oncology and precision medicine.

Classification kind code

Mark Details

Serial Number

2322081

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 257 on 18^th Apr 2024	Designation Notification - Madrid Protocol
Submitted for opposition 1 on 17^th Apr 2024	Created
Submitted for opposition 31 on 17^th Apr 2024	Formalized
Submitted for opposition 228 on 16^th Jan 2024	International Registration
Submitted for opposition 30 on 16^th Jan 2024	Filed